Board of Directors

Joseph Baron, MBA (Co-Founder & CEO)

Partner at Extera Partners, CEO of Janus Biotherapeutics, SVP of Corporate Development BioAssets, M&A Team, Millennium Pharmaceutical, Consultant, Booz Allen, MBA Harvard Business School, MS, Stanford

Jonathan Reis, MD (Co-Founder, Board Member)

Founder, Extera Partners, Head Life Science Armory Securities, Board Members at Janus Biotherapeutics and Acer Biopharmaceuticals

David Dove, MD MBA – Series A Board Member

Dr. Dove has extensive experience in healthcare and leading development stage life science companies. Previously, Dr. Dove was President and CEO of Aeris Therapeutics, which developed and commercialized a treatment for patients with advanced emphysema. Dr. Dove also served as President and CEO of Celadon Science, a biotechnology company focused on skin and wound healing, and as President and CEO of TEI Biosciences, a regenerative medicine company. Dr. Dove received an M.D. degree from New York University and an MBA from the Haas School of Business at Berkeley and a BA in Cell Biology from Middlebury College.